Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App Credit Cards
Go PRO Now
Open App
you are here:
MARKETS

Piramal Pharma Ltd.

BSE: 543635 | NSE: PPLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE0DK501011 | SECTOR: Pharmaceuticals & Drugs

| BSE 204.55 2.45 (1.21%) | |

BSE Live

Oct 29, 13:54
204.55 2.45 (1.21%)
Volume
AVERAGE VOLUME
5-Day
202,141
10-Day
181,871
30-Day
347,882
204,607

  • Prev. Close

    202.10

  • Open Price

    201.45

  • Bid Price (Qty.)

    204.55 (107)

  • Offer Price (Qty.)

    204.70 (339)

NSE Live

Oct 29, 13:54
204.71 2.61 (1.29%)
Volume
AVERAGE VOLUME
5-Day
2,515,762
10-Day
2,308,888
30-Day
5,167,622
1,749,229

  • Prev. Close

    202.10

  • Open Price

    203.15

  • Bid Price (Qty.)

    204.57 (58)

  • Offer Price (Qty.)

    204.68 (36)

Company Facts - Piramal Pharma

Registered Address

Ground Floor, Piramal Ananta,
Agastya Corporate Park,,Kamani Junction,
Mumbai
Maharashtra
400070

Tel: 022-38023000 022-38024000
Fax: 022-
Email: shareholders.ppl@piramal.com
Website: http://www.piramalpharma.com
Group: Piramal Ajay Group

Registrars

MUFG Intime India Pvt. Ltd. C 101, 247 Park, L.B.S. Marg, Vikhroli (West),
Mumbai - 400083
Maharashtra

Tel: 022-49186270, 49186200
Fax: 022-49186060
Email: rnt.helpdesk@linkintime.co.in
Website: http://www.linkintime.co.in

Management - Piramal Pharma

NameDesignation
Nandini Piramal Chairperson
Vivek Valsaraj Executive Director & CFO
S Ramadorai Independent Director
Vibha Paul Rishi Independent Director
Sridhar Gorthi Independent Director
NameDesignation
Peter DeYoung Executive Director
Nathalie Leitch Non Executive Director
Peter Stevenson Independent Director
Jairaj Purandare Independent Director
Source : Dion Global Solutions Limited

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Piramal Pharma Stock Price | Piramal Pharma Stock Quote | Piramal Pharma Results | Piramal Pharma News | View All Related Searches
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347